COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,633 Articles (22,913 medRxiv, 8,720 bioRxiv)

Most recent first Previous |  Page 898: Articles 8971-8980  | Next

Mathematical modelling of COVID-19 transmission dynamics with vaccination: A case study in Ethiopia
Sharbayta, S. S., Desta, H. D., Abdi, T.
10.1101/2022.03.22.22272758 — Posted: 2022-03-23
Risk of SARS-CoV-2 transmission by fomites: a clinical observational study in highly infectious COVID-19 patients
Meister, T. L., Dreismeier, M., Vidal Blanco, E., Brueggemann, Y., Heinen, N., Kampf, G., Todt, D., Nguyen, H. P., Steinmann, J., Schmidt, W. E., Steinmann, E., Quast, D. R., Pfaender, S.
10.1101/2022.03.22.22272773 — Posted: 2022-03-23
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
Lapointe, H. R., Mwimanzi, F., Cheung, P. K., Sang, Y., Yaseen, F., Umviligihozo, G., Kalikawe, R., Speckmaier, S., Moran-Garcia, N., Datwani, S., Duncan, M. C., Agafitei, O., Ennis, S., Young, L., Ali, H., Ganase, B., Omondi, F. H., Dong, W., Toy, J., Sereda, P., Burns, L., Costiniuk, C. T., Cooper, C., Anis, A., Leung, V., Holmes, D. T., DeMarco, M. L., Simons, J., Hedgcock, M., Prystajecky, N., Lowe, C. F., Pantophlet, R., Romney, M. G., Barrios, R., Guillemi, S., Brumme, C. J., Montaner, J. S. G., Hull, M., Harris, M., Niikura, M., Brockman, M. A., Brumme, Z. L.
10.1101/2022.03.22.22272793 — Posted: 2022-03-23
A CNN model for predicting binding affinity changes between SARS-CoV-2 spike RBD variants and ACE2 homologues
Chen, C., Boorla, V. S., Chowdhury, R., Nissly, R. H., Gontu, A., Chothe, S. K., LaBella, L., Jakka, P., Ramasamy, S., Vandegrift, K. J., Surendran Nair, M., Kuchipudi, S. V., Maranas, C. D.
10.1101/2022.03.22.485413 — Posted: 2022-03-23
Pre-exposure prophylaxis with Evusheld™ elicits limited neutralizing activity against the omicron variant in kidney transplant patients
Benotmane, I., Velay, A., Thaunant, O., Gautier-Vargas, G., Olagne, J., Fafi-Kremer, S., Caillard, S.
10.1101/2022.03.21.22272669 — Posted: 2022-03-23
Accuracy of Rapid Antigen Testing across SARS-CoV-2 Variants
Drain, P. K., Bemer, M., Morton, J. F., Dalmat, R., Abdille, H., Thomas, K., Uppal, T., Hau, D., Green, H. R., Hollingworth, M., Aucoin, D. P., Verma, S. C.
10.1101/2022.03.21.22272279 — Posted: 2022-03-23
Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)
Jolliffe, D., Holt, H., Greenig, M., Talaei, M., Perdek, N., Pfeffer, P., Maltby, S., Symons, J., Barlow, N., Normandale, A., Garcha, R., Richter, A., Faustini, S., Orton, C., Ford, D., Lyons, R., Davies, G., Kee, F., Griffiths, C., Norrie, J., Sheikh, A., Shaheen, S., Relton, C., Martineau, A.
10.1101/2022.03.22.22271707 — Posted: 2022-03-23
Topologically engineered antibodies and Fc-fusion proteins: a new class of multifunctional therapeutic candidates for SARS-CoV-2, cancer, and other disease
Capon, D. J., Troitskaya, L., Chan, N. L. S., Fomin, M., Edman, U., Frank, B., Jin, J., Martinelli, R., Capon, B. Z., Ferguson, G. A., Gefter, M. L., Simmons, G.
10.1101/2022.03.23.485397 — Posted: 2022-03-23
Cellulosic copper nanoparticles and a hydrogen peroxide-based disinfectant protect Vero E6 cells against infection by viral pseudotyped particles expressing SARS-CoV-2, SARS-CoV or MERS-CoV Spike protein.
Brault, A., Nere, R., Prados, J., Boudreault, S., Bisaillon, M., Marchand, P., Couture, P., Labbe, S.
10.1101/2022.03.22.485373 — Posted: 2022-03-23
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
Voigt, E. A., Gerhardt, A., Hanson, D., Battisti, P., Reed, S., Singh, J., Mohamath, R., Jennewein, M. F., Bakken, J., Beaver, S., Press, C., Soon-Shiong, P., Paddon, C. J., Fox, C. B., Casper, C.
10.1101/2022.03.22.485230 — Posted: 2022-03-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).